Stockreport

IceCure's ProSense® a Promising Alternative Treatment for Extra-Pelvis Endometriosis: Independent Study Presented at ECR 2024 [Yahoo! Finance]

IceCure Medical Ltd. - Ordinary Shares  (ICCM) 
PDF CAESAREA, Israel March 4, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive [Read more]